e-SPACE Heart Failure 2022

Published: 19 October 2022

  • Views:

    Views Icon 13966
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.

 

Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.

 

For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
 

e-SPACE Heart Failure 2022 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day 1

13 sessions
Plenary Session 1: Implementing the 4 foundational therapies in clinical practice Watch now
Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca) Watch now
Plenary Session 2: Managing your HF patients with comorbidities (part 1) Watch now
Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Meet the expert: Improving exercise capacity and quality of life in patients with heart failure – the role of intravenous iron therapy (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 3: Using SGLT2 in your patients: practical considerations Watch now
Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Plenary Session 4: Managing your HF patients with comorbidities (part 2) Watch now
Meet the expert: Best practice recommendations for the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Watch now
Meet the expert: Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition? (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 5: Managing side effects of HF drugs Watch now
Meet the expert: Sex differences in advanced heart failure Watch now
Plenary Session 6: How to manage the obese patient with HF Watch now

Faculty Biographies

Giuseppe  Galati

Giuseppe Galati

Consultant Cardiologist Heart Failure and Cardiomyopathies

Dr Galati is responsible for the Heart Failure and Cardiomyopathies centre in San Raffaele Hospital Milan, he has relevant expertise in all aspects of Heart Failure: from diagnosis to physiopathology, biomarkers, prognosis, evaluation of congestion, management model to innovation, research and new therapies.

His expertise encompasses the full spectrum of cardiomyopathies: Hypertrophic, Dilated, Arrhtymogenic, Restrictive and Unclassified Cardiomyopathies (i.e. Takotsubo and Left Ventricular Non-Compaction).

Special competence in histopathology and infiltrative diseases: cardiac amyloidosis and sarcoidosis.

New strategies for the management of advanced heart failure as well as expertise in the field of heart transplantation and new assist device are also topics of expertise

  • Fellow of the Heart Failure Association of the ESC
  • Member of the Study Group on Cardiomyopathies 2020-2022 of Heart Failure Association (HFA) of the ESC
View full profile
Altamash Y. Shaikh

Altamash Y. Shaikh

Consultant Endocrinologist

Dr Altamash Y. Shaikh is a Consultant Endocrinologist, Diabetologist and Metabolic Physician based at Saifee Hospital, Mumbai, IN. 

View full profile
Ewa Jankowska

Ewa Jankowska

Prof Ewa Jankowska is Professor of Medicine and Head of Laboratory of Applied Research on Cardiovascular System at the Department of Heart Diseases, Wroclaw Medical University, Poland. Her clinical and research interests include the role of peripheral mechanisms in the progression of heart failure, co-morbidities in heart failure, and experimental model of tachycardia-induced cardiomyopathy.

Prof Jankowska is an Editorial Board member of Cardiac Failure Review.

View full profile

George L Bakris

President Elect

View full profile

Stephan Von Haehling

View full profile
Javed Butler

Javed Butler

Professor of Medicine

Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure.

He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.

Prof Butler has authored more than 900 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals and has been cited numerous times in America’s Best Doctors list.

 

View full profile